Alberto Romagnoli (CFO)
A leading pharma primary packaging manufacturer
Established in 1825, Bormioli pharma is a leading Italian pharma primary packaging manufacturer.
Bormioli Pharma works closely with the pharmaceutical industry and all companies that are working towards the future of healthcare globally. As a world-renowned player in the packaging industry, the company serves the pharmaceutical and biopharmaceutical markets with complete solutions, including glass and plastic bottles, plastic and aluminum closures and accessories.
Bormioli Pharma’s wide product ranges are designed and manufactured looking forward innovation and addressing ever-growing sustainability issues. Moreover, each product is specifically conceived for the destination market thanks to an accurate portfolio segmentation. Bormioli Pharma has a global presence in over 100 countries, with more than 1,400 employees and 9 plants across Europe specialized in the production of glass and plastic packaging. Each year, the company produces more than 7 billion pieces and in 2021 reported annual sales of approximately 260 million euros.
As a partner to the pharmaceutical industry, Bormioli Pharma invests and innovates with one goal in mind: making health a positive practice, available to everyone, kind to the planet.
Bormioli Pharma creates primary packaging solutions for the pharmaceutical sector. This secures the distribution and administration of medicine by helping to protect drugs from deterioration, prolong medications’ stability, and provide accurate dosing. In turn, this contributes to the health of individuals receiving medicinal treatment.
Bormioli Pharma is working hard to integrate circular economy principles into production, including the implementation of energy-saving measures and state of art real-time monitoring of emissions. This includes the installation of new furnaces with higher efficiency which will reduce energy consumption and CO2 emissions.
Bormioli Pharma has corporate objectives regarding the circular economy, particularly around plastics. In 2019, it launched the first pharma-grade sustainable plastic packaging made of recycled polyethylene terephthalate (PET). By 2023, the company aims to achieve pharma-grade certification for a wide range of sustainable products including green polyethylene containers made with 100 per cent bio-based plastic, and BioPET bottles containing up to 30 per cent of material coming from renewable sources.